Polycythemia vera and pregnancy: a case report with the use of hydroxyurea in the first trimester.
Polycythemia vera (PV) is rarely associated with pregnancy. A 34-year-old patient treated with hydroxyurea for PV became pregnant and was referred to our clinic. At the patient's request, pregnancy was continued. The patient's hematocrit level remained below 45% without any treatment throughout her pregnancy, and a healthy male infant (without any congenital malformations or complications) was delivered at 37 weeks. This case report suggests that normal pregnancy and delivery is possible in patients with PV.
Pata
Ozlem
O
Department of Obstetrics and Gynecology, University of Mersin, Turkey.
Tok
C Ekrem
CE
Yazici
Gurkan
G
Pata
Cengiz
C
Oz
A Utku
AU
Aban
Meral
M
Dilek
Saffet
S
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage* / Q000009:adverse effects; D007231:Infant, Newborn; D008297:Male; D011087:Polycythemia Vera / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*; D011261:Pregnancy Trimester, First; D011296:Prenatal Diagnosis; D013723:Teratogens
D000970:Antineoplastic Agents; D013723:Teratogens; D006918:Hydroxyurea